Detailed Information
Cited 19 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFRm advanced NSCLC: FLAURA
- Authors
- Ramalingam, S.; Reungwetwattana, T.; Chewaskulyong, B.; Dechaphunkul, A.; Lee, K. H.; Imamura, F.; Nogami, N.; Ohe, Y.; Cheng, Y.; Cho, B. C.; Cho, E. K.; Vansteenkiste, J. F.; Voon, P. J.; Zhou, C.; Gray, J.; Hodge, R.; Rukazenkov, Y.; Soria, J-C.
- Issue Date
- Sep-2017
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.28
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 28
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.